Fig. 1From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical resultsa Obtaining mesenchymal stem cells from umbilical cord Wharton’s jelly, morphological appearance and final injectable product. b Flow cytometric analysis of WJ-MSCBack to article page